Eldelumab

(Synonyms: BMS-936557; MDX-1100)
Customer Review

Based on 1 Customer Validation

Eldelumab (BMS-936557; MDX-1100) is a fully human IgG1 monoclonal antibody targeting IP-10 (CXCL10). Eldelumab binds and neutralizes IP-10, blocking TNF-α induction, disruption of endothelial junctional complexes, integrin activation, and activated T cell migration. Eldelumab selectively reduces TNF-α release in infected endothelial cells and restores Claudin5, Occludin, ZO-1, and VE-Cadherin expression. Eldelumab can be used for research on hand, foot, and mouth disease (HFMD) and ulcerative colitis.

For research use only. We do not sell to patients.

  • Purity : 99.50%
  • CAS No.: 946414-98-8
  • Molecular Weight:146.64 kDa
  • Storage:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00